Clorox Board Member Matthew Shattock Buys 506 Deferred Units Amid GOJO Deal Optimism, Stock Holds Steady Despite Minor Dip
Clorox insider buys signal confidence after GOJO acquisition, boosting hype but masking a slight share dip; investors eye synergy gains and risk of under‑pricing.
3 minutes to read